Clinical Trials Logo

Clinical Trial Summary

A multi-center, prospective, single-arm post market registry, designed to collect both performance and complication outcomes when same day discharge is enabled by the study device, in sealing multiple femoral venous access sites at the completion of ablation procedures for atrial fibrillation with or without another arrhythmia, performed through 6 - 12 Fr inner diameter (maximum 15F OD) introducer sheaths.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04203329
Study type Observational [Patient Registry]
Source Cardiva Medical, Inc.
Contact
Status Active, not recruiting
Phase
Start date June 30, 2020
Completion date December 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05335525 - Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)
Completed NCT00998023 - Patient Comfort With Vascular Closure N/A
Completed NCT01858636 - Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device
Completed NCT00842179 - Groin Complications Post Percutaneous Coronary Intervention Using Either Manual Compression or PERCLOSE Device N/A
Not yet recruiting NCT06358157 - The Ladera Large Bore Closure Feasibility Study N/A
Completed NCT05027698 - Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study
Completed NCT03756558 - Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System N/A
Not yet recruiting NCT05822804 - Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture N/A